Case Study: Stage 4 Breast Cancer (ER+/PR+/HER2-) Recurrent Invasive Ductal Carcinoma

Firsthand experience with extreme side effects associated with standard oncology options had made this patient apprehensive about this approach, further enhancing her inclination toward alternative treatment options when her cancer recurred with metastatic spread. She was interested in trying Envita Medical Centers' unique precision integrative oncology approach after hearing about the exceptional recovery of one of our late-stage breast cancer patients through news channels. Within 14 weeks of treatment at Envita, she experienced a significant reduction in her disease burden, putting her on the path to a dramatic recovery.



